{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:43:01Z","timestamp":1793961781018,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146985","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T06:25:21Z","timestamp":1756535121000},"page":"146985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Network and pharmacophore guided and BCL2 and HSP90AA1 targeted drug repurposable approaches against rheumatoid arthritis mediated diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"325","author":[{"given":"K.M. Tanjida","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Zaffar","family":"Shibly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146985_bb0005","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40744-020-00252-1","article-title":"A review of the prevalence and unmet needs in the management of Rheumatoid Arthritis in Africa and the Middle East","volume":"8","author":"Almoallim","year":"2021","journal-title":"Rheumatol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146985_bb0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijms24021532","article-title":"Role of sirtuins in the pathogenesis of rheumatoid arthritis","volume":"24","author":"Poniewierska-Baran","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146985_bb0020","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0025","article-title":"Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"Supplement 1","key":"10.1016\/j.ijbiomac.2025.146985_bb0030","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1182\/blood-2022-169045","article-title":"Diffuse large B-cell lymphoma (DLBCL): a structured literature review of the epidemiology, treatment guidelines, and real-world treatment patterns","volume":"140","author":"Garg","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2025.110476","article-title":"Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13","volume":"275","author":"Euler","year":"2025","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-025-13754-4","article-title":"Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study","volume":"25","author":"Zhan","year":"2025","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146985_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/keaa330","article-title":"Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs\u2014a Swedish cohort study of risks by time, drug and lymphoma subtype","volume":"60","author":"Hellgren","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0050","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","author":"Taylor","year":"2021","journal-title":"MDPI"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146985_bb0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/keaa330","article-title":"Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs\u2014a Swedish cohort study of risks by time, drug and lymphoma subtype","volume":"60","author":"Hellgren","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146985_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","volume":"10","author":"Taylor","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146985_bb0065","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/cancers14061509","article-title":"Expression of PD-1, PD-L1 and PD-L2 in lymphomas in patients with pre-existing rheumatic diseases\u2014a possible association with high rheumatoid arthritis disease activity","volume":"14","author":"Hellbacher","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0075","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0080","doi-asserted-by":"crossref","first-page":"1050876","DOI":"10.3389\/fimmu.2022.1050876","article-title":"Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: will immunosuppressants work?","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146985_bb0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","volume":"10","author":"Taylor","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101288","article-title":"Leveraging altered lipid metabolism in treating B cell malignancies","volume":"95","author":"Lee","year":"2024","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146985_bb0095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/biomedicines12030648","article-title":"The possible role of pathogens and chronic immune stimulation in the development of diffuse large B-cell lymphoma","volume":"12","author":"Gergely","year":"2024","journal-title":"Biomedicines"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.146985_bb0100","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114929","article-title":"Phytochemicals targeting JAK\/STAT pathway in the treatment of rheumatoid arthritis: is there a future?","volume":"197","author":"Kour","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120516","article-title":"Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis","volume":"298","author":"Srivastava","year":"2022","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146985_bb0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41379-021-00962-z","article-title":"BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis","volume":"35","author":"Roh","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114184","article-title":"Trends in targeting Bcl-2 anti-apoptotic proteins for cancer treatment","volume":"232","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.963719","article-title":"Analysis of the prognostic, diagnostic and immunological role of HSP90\u03b1 in malignant tumors","volume":"12","author":"Yuan","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146985_bb0130","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10147-025-02782-6","article-title":"HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insights","volume":"30","author":"Shahana","year":"2025","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146985_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052806","article-title":"Heat shock proteins alterations in rheumatoid arthritis","volume":"23","author":"Fouani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12903-022-02304-0","article-title":"HSP90AA1 promotes the inflammation in human gingival fibroblasts induced by Porphyromonas gingivalis lipopolysaccharide via regulating of autophagy","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Oral Health"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146985_bb0145","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/ijms23052806","article-title":"Heat shock proteins alterations in rheumatoid arthritis","volume":"23","author":"Fouani","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146985_bb0150","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.4049\/jimmunol.164.10.5227","article-title":"Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability","volume":"164","author":"Perlman","year":"2000","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0155","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/ar4179","article-title":"IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation","volume":"15","author":"Lee","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0160","article-title":"Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146985_bb0170","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146985_bb0175","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146985_bb0180","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"Ncbi geo: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146985_bb0185","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor","volume":"23","author":"Sean","year":"2007","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146985_bb0190","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146985_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264246","article-title":"An evaluation of RNA-seq differential analysis methods","volume":"17","author":"Li","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0205","series-title":"Exploring Network Structure, Dynamics, and Function Using NetworkX","author":"Hagberg","year":"2008"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146985_bb0210","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0215","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0220","series-title":"Simple and Deep Graph Convolutional Networks","author":"Chen","year":"2020"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40649-019-0069-y","article-title":"Graph convolutional networks: a comprehensive review","volume":"6","author":"Zhang","year":"2019","journal-title":"Comput. Soc. Netw."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10898-020-00949-1","article-title":"Advances in verification of ReLU neural networks","volume":"81","author":"R\u00f6ssig","year":"2021","journal-title":"J. Glob. Optim."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.146985_bb0235","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0240","first-page":"277","article-title":"Comparative analysis of data visualization libraries Matplotlib and Seaborn in Python","volume":"10","author":"Sial","year":"2021","journal-title":"Int. J."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.146985_bb0245","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146985_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/02763869.2020.1826228","article-title":"PubMed 2.0","volume":"39","author":"White","year":"2020","journal-title":"Med. Ref. Serv. Q."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202400293","article-title":"The chemical space spanned by manually curated datasets of natural and synthetic compounds with activities against SARS-CoV-2","volume":"44","author":"Betow","year":"2024","journal-title":"Mol. Inf."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146985_bb0260","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/molecules27051740","article-title":"Virtual screening of natural chemical databases to search for potential ACE2 inhibitors","volume":"27","author":"Yao","year":"2022","journal-title":"Molecules"},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.146985_bb0265","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jcc.27183","article-title":"FRAGMENTISE: a user-friendly, cross-platform tool to create and analyze comprehensive small-molecule fragment databases","volume":"44","author":"Zarnecka","year":"2023","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0270","doi-asserted-by":"crossref","first-page":"16921","DOI":"10.1021\/acsomega.5c01420","article-title":"Fragment libraries from large and novel synthetic compounds and natural products: a comparative chemoinformatic analysis","volume":"10","author":"Ram\u00edrez-Cid","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108397","article-title":"Structure-based virtual screening of novel USP5 inhibitors targeting the zinc finger ubiquitin-binding domain","volume":"174","author":"Wang","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.146985_bb0280","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146985_bb0285","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146985_bb0290","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146985_bb0295","doi-asserted-by":"crossref","first-page":"8.12.1","DOI":"10.1002\/0471250953.bi0812s18","article-title":"Flexible ligand docking with glide","volume":"18","author":"Repasky","year":"2007","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2025.110476","article-title":"Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13","volume":"275","author":"Euler","year":"2025","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146985_bb0305","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.apsb.2022.12.001","article-title":"A novel IRAK4\/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR\/MYD88-mediated NF-\u03baB pathway","volume":"13","author":"Yoon","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.146985_bb0310","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.3390\/cancers15215231","article-title":"Antinuclear antibodies are associated with an increased risk of diffuse large B-cell lymphoma","volume":"15","author":"Frost","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0315","article-title":"Exploring risk factors for autoimmune diseases complicated by non-Hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0320","doi-asserted-by":"crossref","first-page":"1113810","DOI":"10.3389\/fphar.2023.1113810","article-title":"The mechanism of action of paeoniae radix rubra-angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.694507","article-title":"Clinical evidence-guided anti-rheumatoid arthritis study of Shuji tablet in adjuvant-induced arthritis rats and mechanism exploration via network pharmacological approach","volume":"12","author":"Dai","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-323-89775-4.00009-2","article-title":"Pharmacophore modeling and its applications","author":"Tyagi","year":"2022","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146985_bb0335","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ph15050646","article-title":"Drug design by pharmacophore and virtual screening approach","volume":"15","author":"Giordano","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146985_bb0340","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/cancers13061336","article-title":"Novel agents in chronic lymphocytic leukemia: new combination therapies and strategies to overcome resistance","volume":"13","author":"F\u00fcrstenau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.146985_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.146985_bb0350","doi-asserted-by":"crossref","first-page":"2005155","DOI":"10.1002\/adma.202005155","article-title":"Monotherapy and combination therapy using anti-angiogenic nanoagents to fight cancer","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025075427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025075427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:35:03Z","timestamp":1762241703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025075427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"alternative-id":["S0141813025075427"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146985","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network and pharmacophore guided and BCL2 and HSP90AA1 targeted drug repurposable approaches against rheumatoid arthritis mediated diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146985"}}